BHAGCHEMNSEBHAGIRADHA CHEM & INDS LMinimalNeutral
Announced Fri, 25 Sept, 2026 · 15:35 IST

Bhagiradha Chemicals trading window closure from Oct 1, 2026 ahead of Q2 results

BHAGCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.4%Reaction day
₹245.00
prior close
₹244.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+0.2% vs market
Pesticides & Agrochemicals peers, median of 28sector-2.2%+0.8% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.8 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.3
15m
-0.5
30m
-1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.4-1.6+0.2-2.2+0.8
Next day
-2.8-0.6-2.2-3.3+0.5
2d
-3.4-0.8-2.6-3.3-0.1
3d
-2.7-2.1-0.5-4.4+1.8
4d
-6.3-2.1-4.2-5.6-0.8
5d
-1.9-0.8-1.1-4.4+2.5
1w
-9.0-3.8-5.2-6.8-2.2
15d
-14.9-6.9-8.0-9.3-5.6
1m
-16.0pendingpending-10.9-5.1
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

In line with SEBI insider trading rules, Bhagiradha Chemicals has closed its trading window from October 1, 2026 until 48 hours after the company declares its unaudited financial results for Q2 and half year ended September 30, 2026. Designated persons and their immediate relatives cannot trade in the shares during this period. The board meeting date for approving these results will be announced later.

Likely market impact

Routine compliance filing. Signals upcoming Q2 and H1 results announcement. Insiders restricted from trading; no direct retail shareholder impact.